Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Some drugs used to treat immune conditions may cause different types of hair loss.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Phospholipase A2 is necessary for the correct placement of PIN proteins in plant roots, affecting root growth.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.